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Abstract
Rationale The gut-brain axis includes bidirectional communication between intestinal microbiota and the central nervous system.
Bifidobacterium and Lactobacillus spp. have been implicated in psychological health, such as depression, through various
pathways (e.g. inflammation). Research needs a better understanding of direct and indirect effects through examination of
psychological factors that make people susceptible to, or offer protection against, depression.
Objective This study investigated the relationships between gut microbiota, inflammation and psychological risk and resilience
factors for depression.
Methods Forty participants (13 m/27 f) recruited from the general population completed self-report questionnaires for depres-
sion, self-judgement, over-identification and affective and cognitive empathy. Faecal and blood samples were taken to assay
microbiota (Bifidobacterium; Lactobacillus spp.) and pro-inflammatory molecules (C-reactive protein, CRP and interleukin-6,
IL-6), respectively.
Results Hierarchical regression analyses (controlling for sex, age and the shared variance of risk and resilience factors) showed
that (i) cognitive depression was significantly predicted by negative self-judgement and reduced cognitive empathy; (ii) abun-
dance of Lactobacillus spp. was directly related to positive self-judgement but only indirectly to cognitive depression and lower
affective empathy (both through self-judgement); and (iii) CRP was the strongest predictor of reduced cognitive empathy, with
suppression effects seen for age (negative) and IL-6 (positive) after controlling for CRP.
Conclusions Findings suggest that lactobacilli and inflammation may be differentially associated with mood disorder via brain
mechanisms underpinning self-judgement and cognitive empathy, respectively. Further trials investigating interventions to
increase Lactobacillus spp. in depression would benefit from direct measures of self-judgement and affective empathic distress,
whilst those that aim to reduce inflammation should investigate cognitive empathy.
Keywords Brain-gut-microbiotaaxis .Lactobacillus . Inflammation .Depression .Self-judgement .Cognitiveempathy,affective
empathy, over-identification
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Introduction
With a lifetime prevalence of 25%, depression is the leading
cause of disability worldwide, accounting for 33% of the total
disability costs in Europe (1% GDP) (Sobocki et al. 2006;
WHO 2017). Fundamental issues for clinical management
with pharmaceuticals include limited efficacy (approximately
30–50% of patients remain intolerant or unresponsive to phar-
macotherapy), costs and side effects (Epstein et al. 2014). As
such, it is imperative for global wellbeing and economy that
more evidence-based and effective management techniques
are developed with fewer side effects, rapid onset of therapeu-
tic action and lower cost. Recent evidence indicates potential
clinical advantage (e.g. improving mood and emotional pro-
cessing) of targeting the gut-brain axis through modulation of
the microbiota that inhabit the gut (Fond et al. 2015; Liu et al.
2015; Steenbergen et al. 2015; Tillisch et al. 2013).
The gut-brain axis includes bidirectional interactions be-
tween intestinal microbiota and the central nervous system
(Dinan and Cryan 2017). In addition to being regulated by
the brain (e.g. in response to states of stress or fear; Bailey
et al. 2006), the balance between various competing microbi-
ota species influences neural function both directly via the
vagus nerve (Bravo et al. 2011) and indirectly through the
immune system, neurotransmitter synthesis, endocrine func-
tion (e.g. sex and stress hormones) and other signalling mol-
ecules (e.g. Fond et al. 2015; Janik et al. 2016; Liang et al.
2015; Liu et al. 2016; Wang et al. 2016). Whilst much of our
understanding about the brain-gut-microbiota axis is derived
from preclinical and animal studies, which implicate an im-
portant role for Bifidobacterium and Lactobacillus genera in
mood regulation, this has been broadly supported by recent
human studies (Dinan and Cryan 2017; Aizawa et al. 2016;
Pirbaglou et al. 2016; Wallace and Milev 2017; Rieder et al.
2017; Ng et al. 2017; Tillisch et al. 2013). For example, re-
duced levels of gut bifidobacteria and lactobacilli have been
observed in people with major depressive disorder (Aizawa
et al. 2016). Understanding the psychological mechanisms
that underpin these associations would allow for the advance-
ment of more sensitive psychological targets in clinical trials
(Allen et al. 2017).
Probiotic, prebiotic and synbiotic (i.e. combined pro- and
prebiotics) trials in humans to increase gut bifidobacteria and
lactobacilli havemet with some success in ameliorating symp-
toms of depression and anxiety in both non-clinical (healthy
volunteers) and clinical (e.g. major depressive disorder, irrita-
ble bowel syndrome, chronic fatigue syndrome) populations
(Pirbaglou et al. 2016; Rieder et al. 2017). However, negative
findings also exist, including some larger trials (Romijn et al.
2017; Benton et al. 2007), possibly in part reflecting the mul-
tifarious nature of depression and anxiety, as well as the dif-
ferent approaches to fortify lactobacilli. Thus, whilst a
synbiotic supplementation designed to increase bifidobacteria
and lactobacilli did not lower depression and anxiety per se, an
improvement was seen in cognitive reactivity (e.g. rumina-
tion) during sadness (Steenbergen et al. 2015). In another
study, a significant psychological response to supplementation
with Lactobacillus helveticus and Bifidobacterium longum
was only seen in a subgroup of participants with high baseline
vitamin D (Romijn et al. 2017). In a trial comparing the effects
of two prebiotics, namely fructooligosaccharides and galacto-
oligosaccharides, on performance in several experimental
tasks designed to index mood, a shift in emotional bias to-
wards attending to positive words (dot-probe-test) and a re-
duction in salivary cortisol compared to placebo were ob-
served (Schmidt et al. 2015). These findings suggest more
complex relationships between the gut microbiota and
depression—likely with specific aspects of depression or in-
directly through associated psychological risk factors.
Recent models highlight the interplay between empathy
and self-compassion in the development of mood disorders,
including depression (MacBeth and Gumley 2012; Schreiter
et al. 2013). Affective empathy refers to the tendency to feel
another person’s emotions, sometimes referred to as emotional
contagion or responsivity (Reniers et al. 2011). Capacity for
affective empathy protects against some maladaptive person-
ality traits (e.g. psychopathy, narcissism) and promotes
prosocial behaviour, but also carries risk. Taking on empathic
distress from others through heightened affective empathy in
combination with over-identification—that is being self-
absorbed in one’s emotional reaction and suffering (as op-
posed to self-compassion)—can increase risk for depression,
emotional burnout and compassion fatigue. Schreiter et al.
(2013) propose that greater capacity for affective empathy
might underpin greater risk of depression in women. On the
other hand, the ability to conceptualise the distinct perspective
of another person (cognitive empathy) and certain dimensions
of self-compassion, such as positive self-judgement, protect
against this risk (Schreiter et al. 2013). Indeed, the aforemen-
tioned implication of lactobacilli in promoting positive emo-
tional bias (Schmidt et al. 2015) and reducing rumination
(Steenbergen et al. 2015) may well be reflected in a positive
view towards oneself (i.e. positive self-judgement). To our
knowledge, the relationships between these psychological risk
and resilience factors for mood disorder and the microbiota
have not been directly investigated.
One of the mechanisms through which the microbiota
might interact with mood is via the immune system (Rea
et al. 2016). For example, bifidobacteria and lactobacilli have
anti-inflammatory effects, which may underpin their anti-
anxiety and anti-depressant action (Maldonado Galdeano
et al. 2015). The relationship between the immune response
and depression has also been proposed to be bidirectional.
Thus, chronic stress induces elevated hormone (e.g. adrena-
line, noradrenaline and cortisol) release, via the persistent ac-
tivation of the hypothalamic-pituitary-adrenal axis and
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autonomic nervous system that affects the neural regulation of
emotions and immune system function (Kiecolt-Glaser et al.
2015). On the other hand, chronic activation of inflammatory
pathways alters synthesis of certain neurotransmitters (e.g.
serotonin, dopamine), increasing stress responsivity, vulnera-
bility to mood disorders and impaired cognitive function
(Kiecolt-Glaser et al. 2015).
In light of the above findings, the current study investigat-
ed, for the first time to our knowledge, the relationship be-
tween microbiota (bifidobacteria and lactobacilli), inflamma-
tion (CRP, IL-6) and psychological risk and resilience factors
for depression (self-judgement, over-identification, affective
and cognitive empathy). We study these associations in the
general population to investigate both psychological risk and
resilience factors (e.g. positive self-judgement is a resilience
factor that might be compromised in MDD), free from medi-
cation. It was hypothesised that bifidobacteria and lactobacilli
would be associated with reduced depression, inflammation,
over-identification and affective empathy, but increased posi-
tive self-judgement and cognitive empathy. If these associa-
tions are due to interactions with the immune system, they
might be expected to be mediated by measures of
inflammation.
Materials and methods
Participants
A total of 40 participants took part in this study—13 men
(aged 22–67, mean = 36.77, SD = 13.24) and 27 women (aged
19–56, mean = 36.19, SD = 10.72; of which 2 were
breastfeeding). Participants were eligible if they were aged
over 18 years, had fluent English language skills and were
non-smokers and predominantly right-handed. Exclusion
criteria included intake of antibiotics (within the previous
3 months); regular intake of psychotropic or anti-
inflammatory drugs, prebiotic/probiotic or synbiotic supple-
ments (within the previous 4 weeks); use of laxatives, anti-
diarrhoeal medications, enemas or suppositories (within the
previous 4 weeks) or history of colonic irrigation (within the
previous 6 months), gastrointestinal infection (within the pre-
vious 4 weeks), major surgery (within the previous 3 months),
major physical illnesses including gastrointestinal, inflamma-
tory or autoimmune diseases; and personal history of diag-
nosed psychiatric or neurological disorder other than depres-
sion. The majority of participants were Caucasian (n = 33) and
had attained university-level qualification (n = 30; n = 7A lev-
el equivalent; n = 3 other higher education), and were in full-
time employment (n = 25; n = 12 were in full-time education).
Most regularly consumed alcohol (n = 34), and some took
regular prescribed medication (n = 14; n = 7 contraceptives,
n = 3 blood pressure and statins; n = 1 thyroid; n = 1 stomach
acid; n = 1 acne; n = 1 asthma), consumed dietary supplements
(n = 13) and reported food allergies (n = 6). Two participants
reported chronic depression, but were not currently taking
anti-depressants. One participant reported chronic back pain
and one discoid eczema, and one minor surgery (removal of
nasal polyps and septoplasty) within the previous 6 months.
The study procedures were approved by the Business, Law
and Social Sciences ethics committee, Nottingham Trent
University. Written informed consent was provided by all
participants.
Psychometrics
Depression
The Beck Depression Inventory II (BDI-II) has 21 items
assessing cognitive (8 items, α = 0.81) and non-cognitive
(13 items, α = 0.87) domains, with statements ranging in in-
tensity from 0 to 3. Participants were asked to endorse the
most characteristic statements over the past 2 weeks.
Domain subscores were calculated with higher scores
denoting more severe depressive symptoms. The BDI-II has
been validated for clinical and non-clinical adolescents and
adults (Beck et al. 1996; Steer et al. 1999). The BDI-II total
and factor scores show good reliability (Cronbach’s alphas, α,
ranging between 0.74 and 0.93) and construct validity (Steer
et al. 1999).1
Self-judgement and over-identification
Subscales of the self-compassion scale (Neff 2003) were used
to measure self-judgement (5 items, e.g. BI’m disapproving
and judgmental about my own flaws and inadequacies^, α =
0.77) and over-identification (4 items, e.g. BWhen something
upsets me I get carried away with my feelings^, α = 0.81).
Items are rated using a Likert scale ranging from 1 (almost
never) to 5 (almost always). Scores were reverse coded such
that higher scores reflect greater self-compassion (more posi-
tive self-judgement; less over-identification, respectively).
The scales have shown good internal and test-retest (rs =
0.88) reliability and discriminant validity (Neff 2003).
Empathy
The questionnaire for cognitive and affective empathy
(Reniers et al. 2011) is a 31-item scale, containing cognitive
empathy (19 items) and affective empathy (12 items). Items
are rated using a Likert scale from 1 (strongly agree) to 4
(strongly disagree) and computed such that higher scores
1 28 participants (70%) scored in the normal range (between 0 and 10), 11
(17.5%) showed mild mood disturbance (11–16) and 1 (2.5%) participant
showed moderate depression (score of 30).
Psychopharmacology
indicate greater empathy. Previous Cronbach’s alphas for sub-
scales ranged from 0.65 to 0.85 (Reniers et al. 2011).
Procedure
Participants in the current study form a subgroup of a larger
ongoing psychometric project (N = 400). After completion of
the online screening survey, participants received further study
information for the experimental parts and were invited to
register interest for these. All eligible participants who did
not meet any exclusion criteria and resided near the laboratory
location were invited to participate in this study. For the cur-
rent study part, participants were required to provide blood
and stool samples. Psychometric and laboratory testing inter-
val ranged from 0 to 78 days apart (mean = 35.12 days; SD =
22.69).
Faecal samples
Participants were issued with a Fecotainer® (www.fecotainer.
eu/) and detailed instructions regarding stool collection.
Twenty-eight out of 40 participants were able to provide a
sample on the day of testing; the remaining 12 took the
Fecotainer® home and provided it at the earliest possible op-
portunity. Stool samples were aliquoted (1 g per participant)
and frozen at − 20 °C within 2 h of voiding and transported to
the lab for further processing.
Blood samples
Ten milliliters of blood was drawn from the antecubital fossa
using BD Vacutainer® Safety Lok™ blood collection sets
containing ethylenediaminetetraacetic acid (EDTA) as an an-
ticoagulant, and immediately placed on ice. Blood samples
were centrifuged for 15 min (1000×g at 4 °C) within 30 min
of collection. The plasma fraction was then aliquoted into
cryotubes and stored at − 80 °C until analysis.
Processing of biosamples
Faecal sample preparation
Stool samples were thawed and re-suspended in phosphate-
buffered saline (PBS; 0.01 M phosphate buffer, 0.0027 M
potassium chloride and 0.137 M sodium chloride) and
homogenised in a stomacher for 2 min at 460 paddle beats
per minute. The resulting faecal slurry was vortexed with 3-
mm glass beads (VWR) for 30 s before being centrifuged at
400×g for 2 min at room temperature. The supernatant
(375 μL) was fixed in 4% (w:v) (1125 μL) paraformaldehyde
for 4 h at 4 °C. To wash the cells out of paraformaldehyde,
samples were centrifuged at 13,000×g in 1 mL PBS for 5 min
at room temperature; this centrifugation was repeated two
more times, then samples were re-suspended in 150 μL PBS
and stored in ethanol (1:1 by v:v) at − 20 °C for enumeration
by fluorescence in situ hybridisation (FISH).2
Flow cytometry-fluorescence in situ hybridisation
for enumeration of faecal microbial population
Flow-FISH, using fluorescently labelled 16S rRNA–targeted
oligonucleotide probes (Sigma-Aldrich, Steinheim, Germany)
labelled at the 5′ end with fluorochrome Alexa®647, was used
for bacterial enumeration of the faecal samples. A panel of 11
commonly used 16S rRNA oligonucleotide probes targeting
specific groups of bacteria was used. However, only Bif164
(bifidobacteria) and Lab158 (lactobacilli) were investigated in
the current study. The EUBmix probe (linked to the fluoro-
chrome Alexa®488) was used to measure total bacteria within
the samples via a fluorescence detector. From this, bacterial
groups of interest were assessed using probes (linked to fluo-
rochrome Alexa®647) to fluoresce at a different excitation
wavelengths to be detectable in a fluorescence detector
(FL4-H).
Fixed samples were treated with lysozyme TE-FISH buffer
(0.1 M Tris, 0.05M EDTA, 1 mg/mL lysozyme) for 10 min at
room temperature. The sample was washed twice in PBS and
re-suspended in hybridization buffer (0.9 M NaCl, 0.02 M
Tris/HCl, 30% formamide, 0.01% SDS), together with the
oligonucleotide probe of interest. The hybridising mixtures
were incubated overnight at 35 °C before 150 μL of
hybridisation buffer was added to each tube, mixed and cen-
trifuged 3 min at 13,000×g. Supernatant (150 μL) was taken
off and discarded using a pipette. The sample was again cen-
trifuged for 3 min 13,000×g and all the supernatant removed.
The pellet was re-suspended in PBS solution and the sample
was read using the accuri C6 (BD Biosciences, Oxford, UK)
flow cytometer.
ELISA analysis
Plasma samples and reagents were brought to room tempera-
ture prior to analysis. Plasma was diluted 100-fold (CRP only)
and assayed using a 96-well solid-phase quantitative sandwich
enzyme immunoassay (R&D Systems Quantikine® ELISA).
The intra- and inter-assay precision was less than 10% for both
CRP and IL-6, and the mean minimum detectable level of the
assay was 0.010 ng/mL for CRP and 0.039 pg/mL for IL-6 (all
samples exceeded those apart from one IL-6 sample that was
zero). A set of standards was prepared using calibrator diluent
tomake a two-fold dilution series. Fifty microliters of standard
2 Sequencing has been shown to underestimate bifidobacteria (Sim et al. 2012;
Walker et al. 2015), which were key to our interests. FISH is an established
technique which provides absolute quantitative measures (rather than ratios or
abundance) and has been the preferred method for several recent studies (e.g.,
Costabile et al. 2016).
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or sample was added to each well, and all standards and sam-
ples were assayed in duplicate. Duplicate readings of each
standard and sample were averaged, and the average
zero standard optical density was subtracted. A standard
curve was generated by reducing the data using comput-
er software (www.elisaanalysis.com) to generate a four-
parameter logistic (4-PL) curve fit. Concentrations read
from the standard curve were multiplied by the dilution
factor in the case of CRP. Optical density was deter-
mined within 30 min using a microplate reader set to
450 nm with wavelength correction of 570 nm (CRP)
and 650 nm (IL-6).
Statistics
Pearson’s zero-order correlations were used to test the rela-
tionship between the psychometrics (cognitive depression,
non-cognitive depression, self-judgement, over-identification,
affective empathy, cognitive empathy) and their associations
with the biomarkers (lactobacilli, bifidobacteria, CRP, IL-6).
Hochberg’s correction was used to adjust for multiple
comparisons. For the psychometrics, hierarchical linear
regressions were conducted to assess the unique impact
of the psychological risk factors on depression (control-
ling for age and sex). Based on the results, hierarchical
linear regression was used to test for direct associations
of identified biomarkers with (a) depression and (b) the
identified psychological risk factors (controlling for age
and sex, and related psychometric measures). There is
much debate over rules-of-thumb for suitable sample
size in multiple linear regression (Green 1991), which
range from n > 5/predictor variable to n > 400, and as
with the current study, is determined in part by prag-
matics. Nevertheless, according to Green (1991), N = 38
is sufficient to detect large effect sizes with 1–5 predic-
tor variables and N = 41 for 6 predictors. Due to small
sample size, adjusted R2 values are provided in the re-
gression analyses. Sobel’s test was used to test for me-
diation and/or suppression effects.
Results
Zero-order correlations and regression
for psychometric data
Table 1 shows means, standard deviations and zero-order cor-
relations for psychometric measures (including alphas), mi-
crobiota and inflammation. CRP3 (z = 10.32; zlog = 1.74) and
cognitive depression (z = 5.46; zlog = 0.09) were positively
skewed and were normalised through log transformation. All
Cronbach’s alphas were acceptable.
Cognitive depression was significantly negatively correlat-
ed with positive self-judgement (padj = 0.006) and lower over-
identification; however, the latter did not survive correction
(padj = 0.08). Its associations with increased affective and re-
duced cognitive empathy did not reach significance (ps >
0.05). Non-cognitive depression was not associated with any
of the measures. Affective empathy was significantly nega-
tively correlated with lower over-identification (padj < 0.001)
and positive self-judgement (padj = 0.007). (Scatterplots of all
significant associations can be found in the supplementary
material.)
Psychological risk factors of cognitive depression4
A hierarchical linear regression was conducted to test the
unique contribution of psychometric risk factors predicting
cognitive depression, controlling for sex and age (Table 2
for coefficient statistics) and examine any potential suppressor
effects. Sex and age were entered first (model 1), followed by
the self-compassion variables (model 2), and then affective
and cognitive empathy (model 3). Model 1 was non-signifi-
cant, explaining only 6% of the variance in cognitive depres-
sion (R2adj = 0.01, SE = 0.71; sum of squares regression/resid-
ual = 1.19/18.45, df = 2/37, mean square regression/residual =
0.60/0.50, F = 1.20, p = 0.313). Model 2 was significant and
explained a further 21% (R2adj = 0.18.3, SE = 0.64; sum of
squares regression/residual = 5.24/14.40, df = 4/35, mean
square regression/residual = 1.31/0.41, F = 3.18, p < 0.05,
ΔR2 = 0.20.6, ΔF = 4.92, p = 0.013). Model 3 explained only
a further 0.9% of the variance (R2adj = 0.24, SE = 0.62; sum of
squares regression/residual = 7.06/12.58, df = 6/33, mean
square regression/residual = 1.18/0.38, F = 3.08, p < 0.05,
ΔR2 = 0.09, ΔF = 2.38, p = 0.108). Significant associations
were only seen for positive self-judgement and cognitive em-
pathy (both negative).
Zero-order correlations and regressions
for biomarkers
Abundance of Lactobacillus spp. was associated with in-
creased Bifidobacterium spp. (r = 0.34, p = 0.034, padj > 0.05
n.s.) and CRPlog with increased levels of IL-6 (r = 0.37, p =
0.018, padj > 0.05 n.s.). As shown in Table 1, abundance of
Lactobacillus spp. was associated with increased positive self-
judgement (padj < 0.001) and lower over-identification (though
this did not meet adjusted significance padj > 0.05 n.s.), as well
as reduced affective empathy (padj = 0.02) and cognitive depres-
sion [log] (though this again did not meet adjusted significance
3 There was one outlier for CRP (164.85 ng/mL); however, its removal did not
meaningfully change the associations with the psychometric measures.
4 Regression for non-cognitive depression is not reported as all zero-order
correlations and the regression models were non-significant.
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padj > 0.05 n.s.). CRPlog was associated with reduced cognitive
empathy (padj = 0.005). Bifidobacterium spp. and IL-6 were not
associated with psychometric measures.
Lactobacilli in depression and self-judgement
Hierarchical linear regressions were conducted to test the in-
dependence of the relationships between psychometrics and
lactobacilli, controlling for sex and age. The first regression
examined the direct effect of lactobacilli on cognitive depres-
sion (Table 3). Sex and age were entered into an initial model,
followed by lactobacilli (model 2) and then self-judgement
and cognitive empathy (model 3). Model 1 was non-signifi-
cant, explaining only 6% of the variance (R2adj = 0.01, SE =
0.71; sum of squares regression/residual = 1.19/18.45, df = 2/
37, mean square regression/residual = 0.59/0.49, F = 1.20,
Table 1 Means and standard deviations for microbiota, inflammation and psychometrics
α Mean SD cogD ncogD Self-j Over-i cogE affE
Depression
Cognitivelog 0.75 2.15 2.34 1
Non-cognitive 0.79 5.80 4.14 0.625** 1
Self-compassion
Self-judgement 0.73 3.02 0.68 − 0.493** − 0.089 1
Over-identification 0.86 2.99 0.98 − 0.372* − 0.099 0.650** 1
Empathy
Cognitive 0.93 57.35 8.81 − 0.213 − 0.206 − 0.191 − 0.080 1
Affective 0.85 32.63 5.86 0.216 0.048 − 0.499** − 0.534** 0.235 1
Microbiota
Bifidobacteria – 7.79 0.59 − 0.069 0.058 0.086 0.145 0.029 − 0.160
Lactobacilli – 7.51 0.38 − 0.333* − 0.118 0.593** 0.357* −0.091 − 0.444**
Inflammation
CRPlog – 16.20 28.74 0.173 0.152 − 0.046 0.096 0.514** − 0.263
IL-6 – 1.02 0.43 0.179 0.118 − 0.052 0.164 0.022 − 0.113
N = 40; *p < 0.05; **p < 0.01 (in italics, those that survived Hochberg’s corrections); inflammation markers in ng/mL, microbiota numbers are expressed
as mean log10 cells/g fresh faeces. cogD cognitive depression, ncogD non-cognitive depression, self-j self-judgement, over-i over-identification, cogE
cognitive empathy, affE affective empathy
Table 2 Linear regression for
psychometric risk factors in
cognitive depression
B SE Std. beta t p Tolerance VIF
Model 1. Constant 1.220 0.413 2.954 0.005
Sex 0.208 0.238 0.139 0.872 0.389 0.999 1.001
Age − 0.012 0.010 − 0.201 − 1.259 0.216 0.999 1.001
Model 2. Constant 2.913 0.658 4.425 < 0.001
Sex − 0.181 0.250 − 0.121 − 0.724 0.474 0.753 1.329
Age − 0.005 0.009 − 0.084 − 0.559 0.579 0.937 1.068
Self-judgement − 0.487 0.216 − 0.464 − 2.254 0.031 0.495 2.021
Over-identification − 0.075 0.139 − 0.104 − 0.543 0.591 0.571 1.751
Model 3. Constant 4.238 1.214 3.490 < 0.001
Sex − 0.080 0.245 − 0.054 − 0.328 0.745 0.724 1.381
Age − 0.008 0.009 − 0.124 − 0.824 0.416 0.862 1.160
Self-judgement − 0.519 0.215 − 0.494 − 2.415 0.021 0.465 2.152
Over-identification − 0.040 0.143 − 0.054 − 0.277 0.784 0.500 1.998
Cognitive empathy − 0.026 0.012 − 0.323 − 2.172 0.037 0.879 1.138
Affective empathy 0.005 0.022 0.045 0.249 0.805 0.601 1.665
N = 40; dependent variable was cognitive depression; sex coded: 0 =male/1 = female
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p = 0.313). Model 2 was significant and explained a further
9.8% (R2adj = 0.09, SE = 0.68; sum of squares regression/re-
sidual = 3.13/16.51, df = 3/36, mean square regression/residu-
al = 1.04/0.46, F = 2.27, p < 0.09, ΔR2 = 0.09, ΔF = 4.21, p =
0.047). Model 3 was also significant and explained a further
20% (R2adj = 0.26, SE = 0.61; sum of squares regression/resid-
ual = 7.05/12.60, df = 5/34, mean square regression/residual =
1.41/0.37, F = 3.80, p < 0.008, ΔR2 = 0.20, ΔF = 5.29, p =
0.01). The significant associations for lactobacilli in model 2
(p < 0.05) became non-significant (p = 0.67) when positive
self-judgement and cognitive empathy were added to
the model 3 (both significantly negatively related to
cognitive depression).
Following this, a hierarchical regression was run to exam-
ine the direct effects of lactobacilli on positive self-judgement
(controlling for sex and age, and related psychometric
measures; Table 4).5 Sex and age were entered into an initial
model predicting positive self-judgement, followed by cogni-
tive depression, low over-identification and affective empathy
(model 2)6 and finally lactobacilli (model 3). Model 1 was
significant and explained 28% of the variance in self-
judgement (R2adj = 0.24, SE = 0.59; sum of squares regres-
sion/residual = 4.96/12.83, df = 2/37, mean square regres-
sion/residual = 2.48/0.35, F = 7.15, p = 0.002). Model 2 ex-
plained a further 31% (R2adj = 0.53, SE = 0.46; sum of squares
regression/residual = 10.54/7.25, df = 5/34, mean square re-
gression/residual = 2.11/0.21, F = 9.89, p < 0.001, ΔR2 =
0.31, ΔF = 8.73, p < 0.001). Inclusion of lactobacilli (model
3) explained a further 8.7% (R2adj = 0.62, SE = 0.42; sum of
squares regression/residual = 12.10/2.01, df = 6/33, mean
square regression/residual = 2.01/0.17, F = 11.69, p < 0.001,
ΔR2 = 0.09, ΔF = 9.01, p = 0.005). Significant associations
were seen for sex (higher in men), cognitive depression (neg-
ative in model 2, but becomes n.s. in model 3), low over-
identification (positive in models 2 and 3) and lactobacilli
(positive in model 3).
Inflammation in cognitive empathy
A hierarchical regression was run to examine the direct effects
of inflammation on cognitive empathy (controlling for sex and
age; Table 5).7 In model 1, sex and age alone were not signif-
icantly associated with cognitive empathy. Model 2, including
CRPlog and IL-6, significantly explained 44% of the variance
in cognitive empathy (R2adj = 0.37, SE = 0.6.97; sum of
squares regression/residual = 1326.57/1698.53, df = 4/35,
mean square regression/residual = 331.64/48.53, F = 6.83,
p = 0.001, ΔR2 = 0.37, ΔF = 11.46, p < 0.001). CRPlog
remained the strongest predictor of cognitive empathy. In ad-
dition, age showed a negative and IL-6 a trend for a positive
association with cognitive empathy, suggesting suppression
effects, which were confirmed using Sobel’s tests for age
(p = 0.039) and IL-6 (p = 0.028).
Table 3 Linear regression
showing indirect relationship
between lactobacilli and cognitive
depression
B SE Std. beta t p Tolerance VIF
Model 1. Constant 1.220 0.413 2.954 0.005
Sex 0.208 0.238 0.139 0.872 0.389 0.999 1.001
Age − 0.012 0.010 − 0.201 − 1.259 0.216 0.999 1.001
Model 2. Constant 5.786 2.260 2.560 0.015
Sex 0.115 0.233 0.077 0.494 0.624 0.962 1.040
Age − 0.013 0.009 − 0.205 − 1.339 0.189 0.999 1.001
Lactobacilli − 0.598 0.292 − 0.320 − 2.052 0.047 0.962 1.039
Model 3. Constant 5.351 2.325 2.301 0.028
Sex − 0.051 0.242 − 0.034 − 0.212 0.833 0.718 1.392
Age − 0.008 0.009 − 0.128 − 0.880 0.385 0.891 1.122
Lactobacilli − 0.142 0.329 − 0.076 − 0.433 0.668 0.612 1.634
Self-judgement − 0.521 0.213 − 0.496 − 2.442 0.020 0.458 2.184
Cognitive empathy − 0.026 0.012 − 0.320 − 2.245 0.031 0.926 1.080
N = 40; dependent variable was cognitive depression (log); sex coded: 0 =male/1 = female
5 Following the same rationale, similar hierarchical linear regressions were
conducted to test whether lactobacilli have a direct relationship to (a) low
over-identification and (b) affective empathy, respectively; however, no sig-
nificant associations were seen for lactobacilli after controlling for sex, age and
related psychometric measures. Significant associations were seen only for (a)
positive self-judgement (positive) and affective empathy (negative) predicting
lower over-identification, and (b) lower over-identification (negative)
predicting reduced affective empathy.
6 These were entered as predictors as they were significantly correlated with
both positive self-judgement and lactobacilli.
7 As there were no significant associations with CRP or cognitive empathy, no
other psychometric measures were added; however, IL-6 was entered as pre-
dictor because of its significant correlation with CRP.
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Discussion
The current study investigated the relationship between mi-
crobiota, inflammation and psychological risk factors for de-
pression, including poor self-judgement, over-identification,
high affective empathy and low cognitive empathy, in a non-
clinical sample. Multiple linear regression supported a signif-
icant role for negative self-judgement and poor cognitive em-
pathy in explaining variance in cognitive depression. As ex-
pected, the microbiota markers (bifidobacteria and
lactobacilli) were positively correlated with each other and
the same was seen for the inflammation markers (CRP and
IL-6). Although these associations did not survive Hochberg’s
correction, it is likely these reflect true relationships of small-
to-modest effect size and not statistical errors. Whilst
Bifidobacterium spp. and IL-6 were not associated with psy-
chometric measures, the other two markers (Lactobacillus
spp., CRP) showed some distinct associations. Faecal
lactobacilli concentrations were strongly correlated with pos-
itive self-judgement and lower affective empathy, and margin-
al correlations were seen with lower over-identification and
cognitive depression, though these did not survive correction
for multiple comparisons. A follow-up hierarchical regression
confirmed that the significant association of lactobacilli with
cognitive depression (after controlling for age and sex) be-
came non-significant once self-judgement was taken into ac-
count. Despite a relatively small sample size with limited psy-
chometric and biometric range of scores, linear regression
confirmed a strong direct relationship between positive self-
judgement and Lactobacillus spp. after controlling for sex,
age, cognitive depression, over-identification and affective
empathy. CRP was inversely associated with cognitive empa-
thy, but not related with either bifidobacteria or lactobacilli
abundance.
Table 4 Linear regression
showing direct relationship
between lactobacilli and positive
self-judgement
B SE Std. beta t p Tolerance VIF
Model 1. Constant 3.000 0.34 8.71 < 0.001
Sex − 0.680 0.20 − 0.480 − 3.40 0.002 1.00 1.00
Age 0.010 0.01 0.220 1.57 0.13 1.00 1.00
Model 2. Constant 3.232 0.712 4.536 0.000
Sex − 0.353 0.171 − 0.248 − 2.066 0.047 0.831 1.204
Age 0.008 0.007 0.134 1.171 0.250 0.910 1.099
Cog-depressionlog − 0.251 0.114 − 0.264 − 2.205 0.034 0.837 1.195
Over-identification 0.230 0.099 0.333 2.331 0.026 0.588 1.702
Affective empathy − 0.022 0.015 − 0.193 − 1.436 0.160 0.666 1.502
Model 3. Constant − 1.847 1.810 − 1.021 0.315
Sex − 0.346 0.154 − 0.243 − 2.251 0.031 0.831 1.204
Age 0.009 0.006 0.149 1.441 0.159 0.908 1.102
Cog-depressionlog − 0.175 0.106 − 0.184 − 1.657 0.107 0.789 1.268
Over-identification 0.208 0.089 0.301 2.337 0.026 0.584 1.714
Affective empathy − 0.009 0.015 − 0.077 − 0.608 0.547 0.604 1.655
Lactobacilli 0.613 0.204 0.344 3.001 0.005 0.738 1.356
N = 40; dependent variable was positive self-judgement; sex coded: 0 =male/1 = female
Table 5 Linear regression
showing direct relationship
between C-reactive protein (CRP)
and cognitive empathy
B SE Std. beta t p Tolerance VIF
Model 1. Constant 57.39 5.10 11.25 < 0.001
Sex 4.46 2.94 0.24 1.51 0.14 1.00 1.00
Age − 0.08 0.12 − 0.11 − 0.69 0.50 1.00 1.00
Model 2. Constant 66.89 5.87 11.39 < 0.001
Sex 3.38 2.40 0.18 1.41 0.17 0.96 1.04
Age − 0.23 0.10 − 0.30 − 2.25 0.03 0.88 1.14
CRPlog − 4.67 0.98 − 0.69 − 4.77 < 0.001 0.77 1.30
IL-6 5.35 2.83 0.26 1.89 0.07 0.85 1.18
N = 40; dependent variable was cognitive empathy; sex coded: 0 =male/1 = female
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To our knowledge, this is the first study to show a relation-
ship of Lactobacillus spp. with positive self-judgement and
reduced affective empathy. Results are in line with previous
studies implicating the brain-gut-microbiota axis in cognitive
reactivity to sadness (e.g. rumination) (Steenbergen et al.
2015) and emotional bias (Schmidt et al. 2015). Future work
will need to investigate whether shared variance of affective
empathy and self-judgement with lactobacilli reflects shared
neural mechanisms. For example, depression, affective empa-
thy and poor self-compassion are linked to hypersensitivity of
the amygdala and amygdala-hippocampal connectivity
(Doerig et al. 2016). Furthermore, activation of the medial
prefrontal cortex is implicated in self-criticism (i.e. poor self-
judgement) during error processing (Longe et al. 2010), affec-
tive empathy (resting-state fMRI; Luo et al. 2018) and depres-
sion (Murray et al. 2011). Therefore, either or both of these
mechanisms may mediate the relationships between affective
empathy, self-judgement and lactobacilli.
Growing literature supports an effect of microbiota on
brain networks involved in response to and regulation of neg-
ative affect (e.g. response to threat, fear, sadness). For exam-
ple, in animals, Lactobacillus spp. administration and/or pro-
motion ameliorates adverse effects of stress on hippocampal
serotonin, norepinephrine and brain-derived neurotrophic fac-
tor (Liang et al. 2015) and increases hippocampal and prefron-
tal N-acetyl-aspartate, GABA and glutamate: biomarkers that
are associated with depression (Janik et al. 2016). Also, sup-
plementation with Bifidobacterium longum improved
hippocampal-dependent memory and altered frontal midline
EEG, increasing electroencephalographic mobility (Allen
et al. 2016). An effect of the microbiota on amygdala sensi-
tivity to negative emotions (e.g. fear) has been observed in rats
(Hoban et al. 2017) and in humans with irritable bowel syn-
drome (but with no concurrent effect on inflammatory
markers (Pinto-Sanchez et al. 2017)). Furthermore, reduction
in activity in various emotion and viscerosensory networks
(e.g. amygdala, insular and periaqueductal grey) during an
attentional emotion processing task was seen in healthy wom-
en, following 4-week consumption of fermented milk contain-
ing Lactobacillus bulgaricus, Bifidobacterium lactis and
Streptococcus thermophilus (Tillisch et al. 2013). Moreover,
the HPA cortisol release response is attenuated by a prebiotic
that increases Lactobacillus (Schmidt et al. 2015). Another
neuroimaging study found differences in brain structure and
function—in regions associated with emotional, attentional,
and sensory processing—depending on whether women had
higher concentrations of Bacteroides spp. or Prevotella spp.
(Tillisch et al. 2017). Further neuroimaging studies are needed
to investigate these limbic networks in relation to lactobacilli
and psychological mechanisms underpinning depression in
humans, such as self-judgement, over-identification and cog-
nitive and affective empathy. Such studies should also inves-
tigate the role of Lactobacillus and the peripheral nervous
system in subjective aspects of visceral interoception
and enhanced empathy (Critchley and Harrison 2013).
Alternatively, the association between lactobacilli and self-
judgement may reflect an effect of psychological state on the
microbiota. That is, in animal models, stressor exposure has
been shown to disrupt the microbial population associated
with the colonic mucosa, reducing Lactobacillus abundance
(Galley et al. 2014). If this were the case, a stronger associa-
tion might have been expected between general depression
and lactobacilli. Nevertheless, the current study is limited in
determining the direction of the identified relationships, and
therefore, further longitudinal studies are needed. In the cur-
rent study, the largest effects were seen for a more specific
facet of depression (cognitive depression) and associated per-
sonality traits, self-judgement, affective empathy and over-
identification. Future studies, including trials, should thus
use scales that load more on these aspects of depression.
Trials that either manipulate the microbiota to affect self-
judgement and empathy or manipulate these psychological
constructs to affect the microbiota are needed to better under-
stand direction of the currently observed relationships.
Self-judgement or affective empathy was not associated
with inflammatory cytokines. Thus, current data cannot sup-
port the idea of an inflammatory mechanism underpinning the
link between microbiota and these psychological constructs;
however, we only investigated two molecules. A recent meta-
analysis suggests differentiation between inflammatory
markers and subtypes of depression (melancholic, non-
melancholic; Yang et al. 2018). Here, IL-6 and IL-1β were
increased in melancholic subtypes, whilst CRP was higher in
non-melancholic forms. Future studies may investigate other
markers of immune response: both pro-inflammatory and anti-
inflammatory in relation to dispositional traits. Furthermore,
very small doses of microbes within the gastrointestinal tract
affect neurotransmission in several brain regions (i.e.
paraventricular hypothalamus, central nucleus of the amygda-
la, bed nucleus of the stria terminalis), independent to the
activation of an immune response (Goehler et al. 2007).
Thus, alternative pathways might be through a more direct
role in the synthesis of neurotransmitters and their precursors
and/or via the vagus nerve (Bravo et al. 2011) and require
further investigation.
CRP did show a strong negative association with cognitive
empathy, independent of age and sex. This is in line with
studies showing high levels of CRP in autism, which has been
associatedwith poor cognitive empathy (Khakzad et al. 2012).
Also, inflammatory challenge by endotoxin impaired perfor-
mance on an experimental measure of cognitive empathy (i.e.
theory-of-mind) (Moieni et al. 2015). Together with our find-
ings, this suggests that even in the general population, the
presence of inflammation can impair understanding of other
people’s perspectives. Autism, in some cases or in some part,
has been proposed to be underpinned by microbial dysbiosis
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(Liu et al. 2015). However, the current data do not support the
idea that this is through an association between Lactobacillus
spp. and cognitive empathy, and future studies should inves-
tigate microbiota in relation to other dimensions of the autistic
spectrum (e.g. weak central coherence, hyper-systematised
thinking, poor executive control). Currently, it is proposed that
inflammation and lactobacilli may be differentially associated
with mood disorder via networks underpinning cognitive em-
pathy and self-judgement, respectively.
Furthermore, behavioural effects of members of
Bifidobacterium and Lactobacillus can depend on the specific
species or strain. For example, Bifidobacteria can have strain-
specific intrinsic effects on different types of stress-induced be-
haviours and physiological responses in BALB/cmice (Savignac
et al. 2014). Thus, although bifidobacteria were unrelated to psy-
chometric measures in the current study, future work should
investigate specific strains of Bifidobacterium (and those of
Lactobacillus) and their association with psychometric risk for
depression.
After controlling for CRP levels, the non-significant zero-
order association between IL-6 and cognitive empathy moved
towards a positive association, suggesting a suppression ef-
fect, and this shift was confirmed through a significant Sobel
test. Similarly, age showed a negative association with cogni-
tive empathy once CRP levels were controlled. Reduction in
cognitive, but not affective empathy, in late adulthood has
been previously documented (Bailey et al. 2008). Regarding
IL-6, high levels are usually associated with depression and
poor cognition, at least in clinical and ageing populations (see
Wang et al. 2017 for review). However, some evidence
suggests a positive association between IL-6 and cogni-
tive function in some populations, and an inverted U
function has been proposed, such that cognition is im-
proved at moderate IL-6 levels but adversely affected at
very low or very high levels (Kozora et al. 2001; Wang
et al. 2017). Thus, the positive association (after con-
trolling for CRP) between IL-6 and cognitive empathy
warrants further investigation in the general population
compared to clinical groups.
In summary, strong relationships exist between
Lactobacillus spp. and self-judgement, and between CRP
and cognitive empathy. Larger studies are needed, ideally in-
cluding clinical samples (Ng et al. 2017), to confirm associa-
tions between other variables that did not survive correction
for multiple comparisons. These findings suggest further trials
investigating interventions to increase lactobacilli in depres-
sion would benefit from direct measures of self-judgement
and affective empathic distress, whilst those that aim to reduce
inflammation should investigate cognitive empathy. Finally,
future trials should also investigate whether increasing gut
bifidobacteria and lactobacilli boosts clinical effects of psy-
chological therapies (e.g. self-compassion-focused therapies),
through decreased rumination and positive (or less negative)
self-judgement, especially in people with drug-resistant
depression.
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